Metabolic outcomes of bergamot polyphenolic fraction administration in patients treated with second-generation antipsychotics: a pilot study - PubMed (original) (raw)

Clinical Trial

Metabolic outcomes of bergamot polyphenolic fraction administration in patients treated with second-generation antipsychotics: a pilot study

Antonio Bruno et al. J Nutr Biochem. 2017 Feb.

Abstract

Second-generation antipsychotics (SGAs) are notoriously associated with a marked increase in body weight and with a wide range of metabolic adverse effects, and their chronic use is related with an increased risk for the development of metabolic syndrome (MS). Different adjunctive treatments have been proposed to reduce SGAs-induced weight gain and/or metabolic abnormalities with inconsistent or too limited evidence to support their regular clinical use, thus suggesting the need to find new possible treatments. Bergamot polyphenolic fraction (BPF) has been proven effective in patients with MS, as demonstrated by a concomitant improvement in lipemic and glycemic profiles. The present study was aimed to explore the efficacy and safety of BPF treatment on metabolic parameters in a sample of subjects receiving atypical antipsychotics. Fifteen outpatients treated with SGAs assumed BPF at the oral daily dose of 1000 mg/day for 30 days. Fasting levels of glucose, glycated hemoglobin, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and triglycerides were determined. BPF administration resulted in a statistically significant reduction of body weight (P=.004) and in a trend for body mass index decrease (P=.005). No significant differences in other and metabolic parameters were observed. Our findings suggest that BPF, at the daily dose of 1000 mg for 30 days, could be an effective and safe agent to prevent weight gain associated with atypical antipsychotic use. However, further clinical trials with adequately powered and well-designed methodology are needed to better explore the BPF effectiveness on the SGAs-induced weight gain and metabolic side effects.

Keywords: Bergamot polyphenolic fraction; Hyperglycemia; Hyperlipemia; Metabolic syndrome; Second-generation antipsychotics; Weight gain.

PubMed Disclaimer

Cited by

Efficacy of bergamot: From anti-inflammatory and anti-oxidative mechanisms to clinical applications as preventive agent for cardiovascular morbidity, skin diseases, and mood alterations.
Perna S, Spadaccini D, Botteri L, Girometta C, Riva A, Allegrini P, Petrangolini G, Infantino V, Rondanelli M. Perna S, et al. Food Sci Nutr. 2019 Jan 25;7(2):369-384. doi: 10.1002/fsn3.903. eCollection 2019 Feb. Food Sci Nutr. 2019. PMID: 30847114 Free PMC article. Review.
Atherogenic Index Reduction and Weight Loss in Metabolic Syndrome Patients Treated with A Novel Pectin-Enriched Formulation of Bergamot Polyphenols.
Capomolla AS, Janda E, Paone S, Parafati M, Sawicki T, Mollace R, Ragusa S, Mollace V. Capomolla AS, et al. Nutrients. 2019 Jun 4;11(6):1271. doi: 10.3390/nu11061271. Nutrients. 2019. PMID: 31167512 Free PMC article. Clinical Trial.
Effects of Bergamot Polyphenols on Mitochondrial Dysfunction and Sarcoplasmic Reticulum Stress in Diabetic Cardiomyopathy.
Maiuolo J, Carresi C, Gliozzi M, Musolino V, Scarano F, Coppoletta AR, Guarnieri L, Nucera S, Scicchitano M, Bosco F, Ruga S, Zito MC, Macri R, Cardamone A, Serra M, Mollace R, Tavernese A, Mollace V. Maiuolo J, et al. Nutrients. 2021 Jul 20;13(7):2476. doi: 10.3390/nu13072476. Nutrients. 2021. PMID: 34371986 Free PMC article. Review.
Low-Dose of Bergamot-Derived Polyphenolic Fraction (BPF) Did Not Improve Metabolic Parameters in Second Generation Antipsychotics-Treated Patients: Results from a 60-days Open-Label Study.
Bruno A, Pandolfo G, Crucitti M, Cacciola M, Santoro V, Spina E, Zoccali RA, Muscatello MRA. Bruno A, et al. Front Pharmacol. 2017 Apr 11;8:197. doi: 10.3389/fphar.2017.00197. eCollection 2017. Front Pharmacol. 2017. PMID: 28443024 Free PMC article.
Bergamot (Citrus bergamia), a (Poly)Phenol-Rich Source for Improving Osteosarcopenic Obesity: A Systematic Review.
Mazzola G, Rondanelli M, Baron G, Zupo R, Castellana F, Clodoveo ML, Gasparri C, Barrile GC, Seniga M, Schiavi LM, Moroni A, Gulec S, Riso P, Perna S. Mazzola G, et al. Foods. 2024 Oct 27;13(21):3422. doi: 10.3390/foods13213422. Foods. 2024. PMID: 39517207 Free PMC article. Review.

Metabolic outcomes of bergamot polyphenolic fraction administration in patients treated with second-generation antipsychotics: a pilot study - PubMed (original) (raw)